2015
DOI: 10.1039/c5md00362h
|View full text |Cite
|
Sign up to set email alerts
|

Novel N-thiazolyl piperazine-1-carboxamide CCR2 antagonists – investigation of an unexpected reaction with glutathione

Abstract: A series of CCR2 antagonists containing halothiazoles were found to undergo an unexpected reaction with glutathione.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…A few promising drug candidates are shown in Figure . Compound 1 , also known as AZ12567889, has been reported by AstraZeneca to stand out because of its highly potent rodent affinity as well as good pharmacokinetic properties including CNS penetration . Furthermore, it has been used in a preclinical model of neuropathic pain to reverse hyperalgesia .…”
Section: Resultsmentioning
confidence: 68%
See 1 more Smart Citation
“…A few promising drug candidates are shown in Figure . Compound 1 , also known as AZ12567889, has been reported by AstraZeneca to stand out because of its highly potent rodent affinity as well as good pharmacokinetic properties including CNS penetration . Furthermore, it has been used in a preclinical model of neuropathic pain to reverse hyperalgesia .…”
Section: Resultsmentioning
confidence: 68%
“…Compound 1, also known as AZ12567889, has been reported by AstraZeneca to stand out because of its highly potent rodent affinity as well as good pharmacokinetic properties including CNS penetration. 40 Furthermore, it has been used in a preclinical model of neuropathic pain to reverse hyperalgesia. 41 Compounds 2 (INCB8761/PF-4136309) 42 and 3 (INCB3284) 43 both exhibited potent hCCR2 activity, combined with high selectivity over other chemokine receptors and GPCRs and reasonable oral bioavailability.…”
Section: Antagonist Selectionmentioning
confidence: 99%